Login

Journal Front Page

News & Events

  • Call for article for January 2025 issue
  • Submissions of Review, Research Article, Short Communication and Case study are being accepted for the current and future issues before 15 December, 2024 of this journal by online process or editor@ajper.com, or ajper.editor@gmail.com. Further information can be found at www.ajper.com.
  • October 2024 Issue published
  • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, has successfully launch Volume 13, Issue 4 (October 2024 Issue). You can find the article on http://ajper.com/current_issue.php Article also invited for the Next coming Issue from your side. For More details Visit: www.ajper.com
  • Application For Reviewer
  • We are now going to reconstitute our editorial board members of Reviewer. Please send your resume at ajper.editor@gmail.com and be a part of the editorial board member as Reviewer.
  • AJPER Impact facor
  • It is to pleasure that Ajper SJIF imact facor has increse from 5.019 to 7.014. Also global impact factor incresed from 0.654 to 0.765.
  • ICV
  • AJPER Rank with Index Copernicus Value 61.10 due to high reputation at International Level

Abstract

PHARMACOLOGICAL IMPORTANCE OF NELUMBO NUCIFERA: A REVIEW

Shailbala Singh Baghel, Seema Dubey*

Department of Chemistry, Sarojini Naidu Government Girls P.G. (Autonomous)
College, Bhopal (M.P.)

ABSTRACT

Nelumbo nucifera commonly known as Indian lotus has been used as a native medicine in India. The extracts of rhizomes, seeds, flowers and leaves have been reported to have varied therapeutic potential. Several bioactive compounds have been consequential from these plant parts belonging to different chemical groups, including alkaloids, flavonoids, glycosides, triterpenoid, and vitamins etc., which all have their own therapeutic impact. These days’ different parts of lotus have been consumed as functional foods. Thus, lotus can be regarded as a potential nutraceutical source.

Keywords: Nelumbo nucifera, Bioactive, Nutraceutical.


[Full Text Article]